- Home
- MXCT vs VYGR Comparison
MXCT vs VYGR Comparison
Compare MXCT & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXCT
- VYGR
- Stock Information
- Founded
- MXCT 1999
- VYGR 2013
- Country
- MXCT United States
- VYGR United States
- Employees
- MXCT N/A
- VYGR N/A
- Industry
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- MXCT Health Care
- VYGR Health Care
- Exchange
- MXCT Nasdaq
- VYGR Nasdaq
- Market Cap
- MXCT 398.3M
- VYGR 386.1M
- IPO Year
- MXCT 2021
- VYGR 2015
- Fundamental
- Price
- MXCT $3.55
- VYGR $5.66
- Analyst Decision
- MXCT Strong Buy
- VYGR Strong Buy
- Analyst Count
- MXCT 3
- VYGR 8
- Target Price
- MXCT $8.67
- VYGR $17.00
- AVG Volume (30 Days)
- MXCT 627.2K
- VYGR 590.4K
- Earning Date
- MXCT 11-06-2024
- VYGR 11-12-2024
- Dividend Yield
- MXCT N/A
- VYGR N/A
- EPS Growth
- MXCT N/A
- VYGR N/A
- EPS
- MXCT N/A
- VYGR 0.47
- Revenue
- MXCT $45,599,000.00
- VYGR $163,784,000.00
- Revenue This Year
- MXCT N/A
- VYGR N/A
- Revenue Next Year
- MXCT $21.59
- VYGR N/A
- P/E Ratio
- MXCT N/A
- VYGR $12.13
- Revenue Growth
- MXCT 19.85
- VYGR 3.40
- 52 Week Low
- MXCT $3.17
- VYGR $5.19
- 52 Week High
- MXCT $5.55
- VYGR $11.72
- Technical
- Relative Strength Index (RSI)
- MXCT 48.58
- VYGR 38.70
- Support Level
- MXCT $3.17
- VYGR $5.19
- Resistance Level
- MXCT $3.61
- VYGR $5.59
- Average True Range (ATR)
- MXCT 0.26
- VYGR 0.39
- MACD
- MXCT 0.00
- VYGR -0.15
- Stochastic Oscillator
- MXCT 39.09
- VYGR 20.76
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.